By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
DailynewsegyptDailynewsegypt
  • Home
  • Business
    BusinessShow More
    Banks are in the news again. Two bank failures in the US, and the forced takeover of Credit Suisse by UBS in Switzerland, have triggered the worst turmoil in the banking sector since the 2008 financial crisis.
    When banks go bust: the four factors at play – trust, confidence, contagion and systemic risk
    March 26, 2023
    Research centres define optimal investment portfolio amid high inflation
    Research centres define optimal investment portfolio amid high inflation
    March 26, 2023
    Valuation dispute halts SODIC’s acquisition of Orascom for Real Estate
    Valuation dispute halts SODIC’s acquisition of Orascom for Real Estate
    March 26, 2023
    Abu Dhabi Islamic Bank - Egypt achieves net profit of EGP 2.190bn in 2022
    Abu Dhabi Islamic Bank – Egypt achieves net profit of EGP 2.190bn in 2022
    March 26, 2023
    JICA organizes hybrid event titled ‘Promoting Social and Continuous Learning in Egypt and Japan’
    JICA organizes hybrid event titled ‘Promoting Social and Continuous Learning in Egypt and Japan’
    March 26, 2023
  • Politics
    PoliticsShow More
    Israeli Prime Minister Benjamin Netanyahu fired Defense Minister Yoav Gallant who urged a halt to judicial overhaul
    Israeli PM sacks defence minister who urged a halt to judicial overhaul
    March 27, 2023
    Health Minister opens 1st production line of ‘Hepatitis B and Pentavalent’ vaccines in Egypt
    Health Minister opens 1st production line of ‘Hepatitis B and Pentavalent’ vaccines in Egypt
    March 26, 2023
    Al-Sisi follows up on Justice Ministry's efforts to accelerate trial procedures at courts
    Al-Sisi follows up on Justice Ministry’s efforts to accelerate trial procedures at courts
    March 26, 2023
    Egypt participates in Earth Hour initiative 
    Egypt participates in Earth Hour initiative 
    March 26, 2023
    Egypt's Health Minister discuss bilateral cooperation with an Italian delegation 
    Egypt’s Health Minister discuss bilateral cooperation with an Italian delegation 
    March 23, 2023
  • Interviews
    InterviewsShow More
    Government should help Egyptian arts revive its pioneering role: Omar Abdel Aziz
    Government should help Egyptian arts revive its pioneering role: Omar Abdel Aziz
    March 15, 2023
    Interconnected healthcare systems in Africa require political will from North African leaders: Amref official
    Interconnected healthcare systems in Africa require political will from North African leaders: Amref official
    March 12, 2023
    EGX ready for government’s IPOs programme: Chairperson
    EGX ready for government’s IPOs programme: Chairperson
    February 15, 2023
    British International Investment invests $4.5bn in 700 businesses across Africa: Sherine Shohdy
    February 15, 2023
    Valeo has invested around €0.5bn in Egypt over the past 10 years: CEO
    Valeo has invested around €0.5bn in Egypt over the past 10 years: CEO
    December 27, 2022
  • Culture
  • Opinion
  • Sports
  • Lifestyle
Reading: Sandoz, ECS to produce biosimilar for blood cancer medication
Share
Notification
Latest News
Israeli Prime Minister Benjamin Netanyahu fired Defense Minister Yoav Gallant who urged a halt to judicial overhaul
Israeli PM sacks defence minister who urged a halt to judicial overhaul
Politics
Banks are in the news again. Two bank failures in the US, and the forced takeover of Credit Suisse by UBS in Switzerland, have triggered the worst turmoil in the banking sector since the 2008 financial crisis.
When banks go bust: the four factors at play – trust, confidence, contagion and systemic risk
Business Opinion
Meet Yehia Abouseif: Artist and designer hailing from Cairo and now based in New York
Meet Yehia Abouseif: Artist & designer hailing from Cairo and now based in New York
Culture
Research centres define optimal investment portfolio amid high inflation
Research centres define optimal investment portfolio amid high inflation
Business
Valuation dispute halts SODIC’s acquisition of Orascom for Real Estate
Valuation dispute halts SODIC’s acquisition of Orascom for Real Estate
Business
Aa
Aa
DailynewsegyptDailynewsegypt
  • Home
  • Business
  • Politics
  • Interviews
  • Culture
  • Opinion
  • Sports
  • Lifestyle
  • Home
  • Business
  • Politics
  • Interviews
  • Culture
  • Opinion
  • Sports
  • Lifestyle
Have an existing account? Sign In
Follow US
  • Advertise
© 2023 DNE News. All Rights Reserved.
Dailynewsegypt > Blog > Business > Sandoz, ECS to produce biosimilar for blood cancer medication
Business

Sandoz, ECS to produce biosimilar for blood cancer medication

Daily News Egypt
Last updated: 2020/10/21 at 12:05 AM
By Daily News Egypt 4 Min Read
Share
SHARE

Sandoz Egypt announced that it has partnered with the Egyptian Cancer Society (ECS) to launch rituximab biosimilar, a monoclonal antibody used in the treatment of Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukaemia (CLL).

The partnership is an important step in expanding access to global standard-care treatment for two of the most prevalent types of blood cancer. The newly approved antibody addresses vital patient needs, while simultaneously supporting the sustainability of the Egyptian healthcare system.

A virtual scientific symposium will be held on 23 October to announce the availability of rituximab in Egypt.

“While NHL ranks 10th for men and 12th for women in terms of cancer incidence worldwide, in Egypt the risk of being diagnosed with the disease is even higher, with NHL representing the third most common cancer,” said Mohamed Abdel Moaaty Samra, Head of the Medical Oncology and Hematology Department, at Cairo University’s National Cancer Institute (NCI). “This launch is great news for Egyptian patients, making critical treatment more widely available to them.”

Samra added, “Rituximab is considered a standard of care and a first-line treatment in the management of many hematologic malignancies, and the approval of the first rituximab biosimilar in Egypt offers a substantially more affordable yet equally effective treatment alternative.”

By freeing up budgets, biosimilars help make funds available to treat other devastating illnesses, thereby supporting the sustainability of the healthcare system, while at the same time expanding access to treatment.

“Biosimilars are the successors of biologic medicines, known as ‘reference drugs’, with these therapies known to play a key role in the treatment of several cancers including lymphoma (Non-Hodgkin Lymphoma (NHL),” said Hamdy Abdel-Azim, Professor of Clinical Oncology at Cairo University’s Faculty of Medicine. “Unfortunately, the high cost of these reference biologicals represents a major challenge to patient access to treatment, a challenge that is encountered even in developed countries.”

Based on the latest reports issued by the World Health Organization (WHO), several million patients lack access to essential medicines. As a result, numerous biosimilar drugs have been introduced over the last few years that can provide equivalent safety and efficacy compared with their parent biological.

Sandoz’s rituximab biosimilar is one of these, and one of the first approved biosimilars in the treatment of NHL, with an unequivocally proven efficacy and safety in the treatment of these patients.

The use of rituximab in the treatment of NHL, could reduce about 40% of the total expenditure on treating the disease, compared to the use of the reference drug.“The launch of our first rituximab biosimilar in Egypt is a beacon of hope for many patients and represents a huge milestone for Sandoz. This launch is a testament to our commitment to expanding the availability of life changing and potentially lifesaving medications around the world,” said Sameh Elbagoury, Country Head for Sandoz Egypt and Libya.

“Rituximab is listed as one of the World Health Organization (WHO)’s essential biologic medicines for cancer patients and the introduction of the rituximab biosimilar by Sandoz represents a clear added value to the treatment of blood cancers in Egypt. Having demonstrated the same efficacy, safety, and quality in clinical trials as the reference medicine has, rituximab of Sandoz was approved by the European Medicines Agency (EMA) more than three years ago,” said Peter Effat, Medical Head for Sandoz Egypt.

You Might Also Like

When banks go bust: the four factors at play – trust, confidence, contagion and systemic risk

Research centres define optimal investment portfolio amid high inflation

Valuation dispute halts SODIC’s acquisition of Orascom for Real Estate

Abu Dhabi Islamic Bank – Egypt achieves net profit of EGP 2.190bn in 2022

JICA organizes hybrid event titled ‘Promoting Social and Continuous Learning in Egypt and Japan’

TAGGED: blood cancer, ECS, Sandoz
Share this Article
Facebook Twitter Email Print
Previous Article AFD’s Proparco invests $11m in Egypt-focused LCP Fund II
Next Article Egypt, WBG cooperation portfolio amounts to $8bn
Ad image

Stay Connected

Facebook Like
Twitter Follow
Instagram Follow
Youtube Subscribe

Latest News

Israeli Prime Minister Benjamin Netanyahu fired Defense Minister Yoav Gallant who urged a halt to judicial overhaul
Israeli PM sacks defence minister who urged a halt to judicial overhaul
Politics
Banks are in the news again. Two bank failures in the US, and the forced takeover of Credit Suisse by UBS in Switzerland, have triggered the worst turmoil in the banking sector since the 2008 financial crisis.
When banks go bust: the four factors at play – trust, confidence, contagion and systemic risk
Business Opinion
Meet Yehia Abouseif: Artist and designer hailing from Cairo and now based in New York
Meet Yehia Abouseif: Artist & designer hailing from Cairo and now based in New York
Culture
Research centres define optimal investment portfolio amid high inflation
Research centres define optimal investment portfolio amid high inflation
Business
//
Egypt’s only independent daily newspaper in English. Discuss the country’s latest with the paper’s reporters, editors, and other readers.

Quick Link

  • Home
  • Business
  • Politics
  • Interviews
  • Culture
  • Opinion
  • Sports
  • Lifestyle

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!

© 2023 DNE News. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc..

Zero spam, Unsubscribe at any time.

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?